A new model to study neurodegeneration in ataxia oculomotor apraxia type 2
- PMID: 26231220
- PMCID: PMC4581605
- DOI: 10.1093/hmg/ddv296
A new model to study neurodegeneration in ataxia oculomotor apraxia type 2
Abstract
Ataxia oculomotor apraxia type 2 (AOA2) is a rare autosomal recessive cerebellar ataxia. Recent evidence suggests that the protein defective in this syndrome, senataxin (SETX), functions in RNA processing to protect the integrity of the genome. To date, only patient-derived lymphoblastoid cells, fibroblasts and SETX knockdown cells were available to investigate AOA2. Recent disruption of the Setx gene in mice did not lead to neurobehavioral defects or neurodegeneration, making it difficult to study the etiology of AOA2. To develop a more relevant neuronal model to study neurodegeneration in AOA2, we derived neural progenitors from a patient with AOA2 and a control by induced pluripotent stem cell (iPSC) reprogramming of fibroblasts. AOA2 iPSC and neural progenitors exhibit increased levels of oxidative damage, DNA double-strand breaks, increased DNA damage-induced cell death and R-loop accumulation. Genome-wide expression and weighted gene co-expression network analysis in these neural progenitors identified both previously reported and novel affected genes and cellular pathways associated with senataxin dysfunction and the pathophysiology of AOA2, providing further insight into the role of senataxin in regulating gene expression on a genome-wide scale. These data show that iPSCs can be generated from patients with the autosomal recessive ataxia, AOA2, differentiated into neurons, and that both cell types recapitulate the AOA2 cellular phenotype. This represents a novel and appropriate model system to investigate neurodegeneration in this syndrome.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Figures
Similar articles
-
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).Cerebellum. 2019 Jun;18(3):448-456. doi: 10.1007/s12311-019-01012-w. Cerebellum. 2019. PMID: 30778901 Free PMC article.
-
SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation.Autophagy. 2021 Aug;17(8):1889-1906. doi: 10.1080/15548627.2020.1796292. Epub 2020 Aug 7. Autophagy. 2021. PMID: 32686621 Free PMC article.
-
Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2.Hum Mol Genet. 2014 Sep 15;23(18):4758-69. doi: 10.1093/hmg/ddu190. Epub 2014 Apr 23. Hum Mol Genet. 2014. PMID: 24760770 Free PMC article.
-
SUMOylated Senataxin functions in genome stability, RNA degradation, and stress granule disassembly, and is linked with inherited ataxia and motor neuron disease.Mol Genet Genomic Med. 2021 Dec;9(12):e1745. doi: 10.1002/mgg3.1745. Epub 2021 Jul 14. Mol Genet Genomic Med. 2021. PMID: 34263556 Free PMC article. Review.
-
Senataxin: A key actor in RNA metabolism, genome integrity and neurodegeneration.Biochimie. 2024 Feb;217:10-19. doi: 10.1016/j.biochi.2023.08.001. Epub 2023 Aug 7. Biochimie. 2024. PMID: 37558082 Review.
Cited by
-
Unpaved roads: How the DNA damage response navigates endogenous genotoxins.DNA Repair (Amst). 2022 Oct;118:103383. doi: 10.1016/j.dnarep.2022.103383. Epub 2022 Aug 2. DNA Repair (Amst). 2022. PMID: 35939975 Free PMC article. Review.
-
Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2.Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2114314119. doi: 10.1073/pnas.2114314119. Proc Natl Acad Sci U S A. 2022. PMID: 35042798 Free PMC article.
-
Flap Endonuclease 1 Endonucleolytically Processes RNA to Resolve R-Loops through DNA Base Excision Repair.Genes (Basel). 2022 Dec 29;14(1):98. doi: 10.3390/genes14010098. Genes (Basel). 2022. PMID: 36672839 Free PMC article.
-
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).Cerebellum. 2019 Jun;18(3):448-456. doi: 10.1007/s12311-019-01012-w. Cerebellum. 2019. PMID: 30778901 Free PMC article.
-
Human senataxin is a bona fide R-loop resolving enzyme and transcription termination factor.Nucleic Acids Res. 2023 Apr 11;51(6):2818-2837. doi: 10.1093/nar/gkad092. Nucleic Acids Res. 2023. PMID: 36864660 Free PMC article.
References
-
- Moreira M.C., Klur S., Watanabe M., Nemeth A.H., Le Ber I., Moniz J.C., Tranchant C., Aubourg P., Tazir M., Schols L. et al. (2004) Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat. Genet., 36, 225–227. - PubMed
-
- Anheim M., Monga B., Fleury M., Charles P., Barbot C., Salih M., Delaunoy J.P., Fritsch M., Arning L., Synofzik M. et al. (2009) Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain, 132, 2688–2698. - PubMed
-
- Suraweera A., Lim Y., Woods R., Birrell G.W., Nasim T., Becherel O.J., Lavin M.F. (2009) Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum. Mol. Genet., 18, 3384–3396. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources